U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 022350

Expand all

ONGLYZA (SAXAGLIPTIN HYDROCHLORIDE)
EQ 2.5MG BASE
Marketing Status: Prescription
Active Ingredient: SAXAGLIPTIN HYDROCHLORIDE
Proprietary Name: ONGLYZA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 2.5MG BASE
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N022350
Product Number: 001
Approval Date: Jul 31, 2009
Applicant Holder Full Name: ASTRAZENECA AB
Marketing Status:  Prescription
Patent and Exclusivity Information
ONGLYZA (SAXAGLIPTIN HYDROCHLORIDE)
EQ 5MG BASE
Marketing Status: Prescription
Active Ingredient: SAXAGLIPTIN HYDROCHLORIDE
Proprietary Name: ONGLYZA
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 5MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N022350
Product Number: 002
Approval Date: Jul 31, 2009
Applicant Holder Full Name: ASTRAZENECA AB
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top